NOXXON Pharma hosts key opinion leader symposium
NOXXON Pharma AG (“NOXXON” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on cancer tre…
NOXXON Pharma AG (“NOXXON” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on cancer tre…
. - Operating income: EUR 37.7 million (2008: EUR 31.0 million; +22%) - Operating profit (EBITDA): EUR 4.2 million (20…